Analysts Cut Earnings Estimates for Agios Pharma (AGIO)—But Some Still Target $56–$57
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) is a biopharmaceutical company built on the foundation of pioneering research in cellular metabolism…
Browsing Tag